Moderna Asks FDA to OK Updated Covid-19 Shot

  • 📰 WSJhealth
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 53%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Moderna has submitted to the FDA an application for authorization of Covid-19 shot that targets Omicron subvariants BA.4 and BA.5, as well as original strain of the coronavirus.

Company tweaked its vaccine to target new versions of the coronavirus; says it can ship doses in September if regulators sign off on it

Since the start of the Covid-19 pandemic in 2020, the scientific understanding of its transmission and prevention has evolved. WSJ’s Daniela Hernandez explains what strategies have worked for stemming the spread of the virus and which are outdated in 2022. Illustration: Adele MorganModerna Inc. has asked U.S. regulators to authorize a new version of its Covid-19 vaccine that targets the latest coronavirus strains.

Moderna said on Tuesday that it is ready to ship doses of the new shot in September if it is cleared by the Food and Drug Administration. Health authorities have been seeking such boosters for a

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 413. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer Seeks Approval for Updated COVID BoosterPfizer has sent an application to the FDA for emergency use authorization of its updated COVID-19 booster vaccine for the fall, the company announced Monday.
Source: WebMD - 🏆 709. / 51 Read more »